Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Isopenicillin N synthase (IPNS) is a non-heme iron-dependent enzyme that catalyzes the oxidative cyclization of the tripeptide δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine (ACV) to isopenicillin N. This reaction constitutes the central step in the formation of the β-lactam ring, a core structure widely found in penicillin and cephalosporin antibiotics. The enzyme acts as an oxidoreductase, coupling oxygen reduction with the cyclization of ACV, and is a member of the non-heme iron(II)-dependent oxidase superfamily, sharing mechanistic features with other 2-histidine-1-carboxylate facial triad oxygenases. IPNS is not itself a drug target or human protein, but regulation and optimization of its activity are crucial in industrial production of β-lactam antibiotics. The enzyme is sometimes referred to as isopenicillin N synthetase in older literature[1][2][3][4][5][7][8][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Isopenicillin N synthase (IPNS).